INVEST IN TRUBRAIN TODAY!
Wearable Tech for Anxiety
$1,319,294.40 Raised
Offering Circular | Selected Risks Related to this Offering | TruBrain's SEC EDGAR Page
For more information on TriplePulse, Inc. (TruBrain), download and review the Offering Circular. The Offering Circular should be reviewed before making an investment decision.
.......
.......
Overview
Tackle Anxiety with TruBrain
Wearable tech can help improve how you exercise, sleep, and now.. how you think. Introducing the TruBrain wearable. The power to fight anxiety, without serious side effects - all with the click of a button.
Treat anxiety in a better, non-pharmaceutical way thanks to TruBrain. While most anxiety treatments involve Rx pills that carry side effects, our neuroscience team has built a smart wearable that conquers anxiety at the source, your brain. Built in collaboration with Tri̇di̇ Teknoloji̇ and a notable European industrial design team.
Taking the leading brand in cognitive healthcare to new heights. Join the team with $20M in sales and common investors in AirBnB and Uber.
WATCH Joe Rogan discuss Anxiety & the Brain with Dr. Andrew Hill
The Problem
Anxiety is the enemy of cognitive health
.......
.....
......
.......
..........
..........
The market
Demand for anxiety treatments is growing
Anxiety is crippling to the cognitive health of nearly 125M Americans. And that number is growing. The World Health Organization estimates that since 2020, the amount of people suffering with anxiety has increased 25% worldwide.
Large hardware technology firms often avoid the medical device category due to the compliance and scientific expertise required, leaving an opportunity for more nimble, specialized brands like TruBrain to build market share.
the solution
Wearable Tech for Anxiety
.......
.......
.......
Our team has spent considerable time validating our path to market. We believe that it is optimal for us to start as a Class II medical device for anxiety, versus Class III for depression. This allows us to save considerable time, money, and risk of Cranial Electrotherapy Stimulators achieving FDA Class III status.
Traction
.......
.......
.......
Customers 🖤 TruBrain
TruBrain customers come from all walks of life and work in nearly every profession. Members of the armed forces order TruBrain to more than 70 bases around the globe. Parents take TruBrain after a long day of work so they’ll still have energy to read to their kids and help them with their homework. Writers, producers, and artists swear by TruBrain to boost their creative process. Our customers live in over 80 countries around the world. We work to offer compelling, proactive, healthy alternatives to low-performance packaged foods and over-stimulating pharmaceuticals.
*These testimonials may not be representative of the experience of other customers and are not a guarantee of future performance or success
In the Press
These testimonials may not be representative of the experience of other customers and are not a guarantee of future performance or success
We read minds. Literally.
At TruBrain, our focus is human performance, and our products are designed to enhance your brain's natural abilities. We bring high-performance food and beverage nutrition that delivers positive, measurable outcomes to mainstream consumers. Brainwave measurement is at the core of our origin as a company. We never claimed to be the smartest people on the planet, but we know some of the people who are – artists, surgeons, CEOs, and musicians. So we picked their brains, literally. We studied their thought patterns, their ability to handle stress, how they thought on their feet, and how they dealt with distractions. This led to the understanding of optimal brainwave patterns and the beginning of our journey to help people find their true brain.
.......
.......
.......
OUR TEAM
Consumer execs & neuroscience nerds
We’re led by a visionary founder and veteran leadership with wide experience in neuroscience, healthcare, & consumer experience. Our CEO, Chris Thompson, has deep industry experience in consumer packaged goods - he managed billion dollar brands for Unilever, one of the largest CPG companies in the world. We use what we sell. Whether it is Chris testing Ketones during endurance training or Dr. Andrew Hill testing the latest neurotechnology in the EEG brain lab - we take it, we test it, we share it, we improve it. We have fostered a team whose collective efforts are all driven toward elevating the lives of our customers. Our purpose is to empower people to do their best thinking.
Our Investors
WHY INVEST
Expand with us
Our customers asked us to work on a large barrier in their way of performance - anxiety. We are so excited to attack the anxiety market with our wearable technology by top neuroscientists. We believe this will offer a compelling alternative to pharmaceuticals that have many side effects and will further our reach and status as the leading brand in cognitive healthcare.
Our mission is to make high function solutions accessible to mainstream consumers. Our products deliver a material benefit in people’s lives, and our role is to help them access these benefits. We believe the direct relationship with consumers is the most valuable component in the cognitive healthcare system, and we work to offer compelling, proactive health alternatives to low-function packaged goods and overly stimulating pharmaceuticals.
The expansion of our product portfolio to include wearables, and the ability to offer a personalized healthcare experience only furthers our standing as one of the leading brands in the space. We think that through our brand equity, technology, extensive press coverage, and market timing, we will scale to widespread acceptance.
Join us and say hello to your TruBrain.
Chris Thompson, CEO
Footnotes
[3] - https://bit.ly/36efVUe
[4] - https://www.nytimes.com/2004/10/12/business/company-news-abbott-to-acquire-eas-for-320-million.html
[10] - https://pubmed.ncbi.nlm.nih.gov/30597564/
[12] - https://www.sciencedaily.com/releases/2018/07/180710104631.htm
---
AN OFFERING STATEMENT REGARDING THIS OFFERING HAS BEEN FILED WITH THE SEC. THE SEC HAS QUALIFIED THAT OFFERING STATEMENT, WHICH ONLY MEANS THAT THE COMPANY MAY MAKE SALES OF THE SECURITIES DESCRIBED BY THE OFFERING STATEMENT. IT DOES NOT MEAN THAT THE SEC HAS APPROVED, PASSED UPON THE MERITS OR PASSED UPON THE ACCURACY OR COMPLETENESS OF THE INFORMATION IN THE OFFERING STATEMENT.
THE OFFERING CIRCULAR THAT IS PART OF THAT OFFERING STATEMENT CAN BE FOUND HERE.
THE OFFERING MATERIALS MAY CONTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER THINGS, THE COMPANY, ITS BUSINESS PLAN AND STRATEGY, AND ITS INDUSTRY. THESE FORWARD-LOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY AVAILABLE TO THE COMPANY’S MANAGEMENT. WHEN USED IN THE OFFERING MATERIALS, THE WORDS “ESTIMATE,” “PROJECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “EXPECT” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS, WHICH CONSTITUTE FORWARD LOOKING STATEMENTS. THESE STATEMENTS REFLECT MANAGEMENT’S CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD-LOOKING STATEMENTS. INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE ON WHICH THEY ARE MADE. THE COMPANY DOES NOT UNDERTAKE ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER SUCH DATE OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.
WHILE THE COMPANY HAS SIGNED A QUOTATION AGREEMENT TO TRADE THE SECURITIES OFFERED ON STARTENGINE SECONDARY’S NEW ALTERNATIVE TRADING SYSTEM (THE “ATS”), A COMPANY WHICH INTENDS TO BE QUOTED ON THE MARKETPLACE WILL BE SUBJECT TO CERTAIN REQUIREMENTS WHICH THE COMPANY MAY OR MAY NOT BE ABLE TO SATISFY IN A TIMELY MANNER. EVEN IF A COMPANY IS QUALIFIED TO QUOTE ITS SECURITIES ON THE MARKET, THERE IS NO GUARANTEE AN ACTIVE TRADING MARKET FOR THE SECURITIES WILL EVER DEVELOP, OR IF DEVELOPED, BE MAINTAINED. YOU SHOULD ASSUME THAT YOU MAY NOT BE ABLE TO LIQUIDATE YOUR INVESTMENT FOR SOME TIME OR BE ABLE TO PLEDGE THESE SHARES AS COLLATERAL.
ABOUT
HEADQUARTERS
3103 Neilson Way, Suite D
Santa Monica, CA 90405
WEBSITE
View Site
TruBrain is launching wearable technology for anxiety, using established technology that has been cleared by the FDA. Anxiety Market size of $11 Billion. Designed by PhD neuroscientists and notable European industrial designers. Profitable brand with $20 million in lifetime sales. Featured in Forbes, CNBC & Bloomberg.
TERMS
TruBrain
Overview
PRICE PER SHARE
$0.43
DEADLINE
Jun 15, 2023
VALUATION
$24.34M
FUNDING GOAL
$10k - $9.31M
Breakdown
MIN INVESTMENT
$473
MAX INVESTMENT
$1,999,999.95
MIN NUMBER OF SHARES OFFERED
23,255
MAX NUMBER OF SHARES OFFERED
21,662,790
OFFERING TYPE
Equity
ASSET TYPE
Common Stock
SHARES OFFERED
Common Stock
Maximum Number of Shares Offered subject to adjustment for bonus shares
x
NEW UPDATES
05.31.23
TruBrain has raised over $1.3M!
We just crossed another milestone.. over $1.3 Million raised! With the backing of 4 VC funds and 2,000+ StartEngine investors, TruBrain has a strong investor community.
We are a profitable, venture backed company that is disrupting an $11 Billion market through the use of neuroscience and wearable technology.
Remember, every investor gets $325 worth of free product along with their shares!
Become an investor for less than $500 today!
This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
PRESS
ALL UPDATES
05.30.23
15 Days Left to Invest!
There are only 15 days left to invest in TruBrain and their wearable technology that will help 125 million Americans suffering with anxiety. This is an $11 Billion market!
Don’t forget! TruBrain is profitable, with over $20 Million in sales, and has the backing of 4 Venture Capital Firms.
Invest now and get $325 worth of free product and up to a 50% lifetime discount!
Join over 2,000+ investors that have joined one of the leaders in cognitive healthcare.
This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. In addition, as described in the Offering Circular, the Company retains the right to continue the offering beyond the Termination Date, in its sole discretion.
05.25.23
20 Days Left to Invest!
There are only 20 days left to invest in TruBrain and their wearable technology that will help 125 million Americans suffering with anxiety. This is an $11 Billion market!
Don’t forget! TruBrain is profitable, with over $20 Million in sales, and has the backing of 4 Venture Capital Firms.
Invest now and get $325 worth of free product and up to a 50% lifetime discount!
Join over 2,000+ investors that have joined one of the leaders in cognitive healthcare.
This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. In addition, as described in the Offering Circular, the Company retains the right to continue the offering beyond the Termination Date, in its sole discretion.
05.24.23
Big Pharma’s Anxiety Problem
There are nearly 20 anxiety drugs on the market. But many of these pharmaceutical drugs that are pushed by Big Pharma come with a whole host of debilitating side effects. That is why many people seek treatment for anxiety outside of these Big Pharma drugs. That is where TruBrain comes in. The technology in TruBrain’s new Wearable Device has been shown to be effective at treating Anxiety, without the side effects that come with pharmaceutical drugs. It’s also FDA Cleared tech!
See why customers choose Wearable Technology instead of Pharmaceuticals
This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
05.23.23
Harvard Studies Neurostimulation for the Brain
The technology underlying TruBrain’s new Wearable Device is being studied at one of the most prestigious universities around the globe, Harvard. In a recent article, Harvard Health Publishing mentions “hype around transcranial neurostimulation is growing for an expanding list of conditions such as depression, ADHD, and even Alzheimer's disease.” In another article, by a Psychiatry Advisor, they mention the potential for neurostimulation to treat ADHD. All of these potential use cases are extremely exciting for the future. For now, the technology in TruBrain’s device is FDA Cleared for Anxiety. We’re excited about what’s on the horizon.
Learn more about the tech in Harvard's study
This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
05.20.23
25 Days Left to Invest!
There are only 25 days left to invest in TruBrain and their wearable technology that will help 125 million Americans suffering with anxiety. This is an $11 Billion market!
Don’t forget! TruBrain is profitable, with over $20 Million in sales, and has the backing of 4 Venture Capital Firms.
Invest now and get $325 worth of free product and up to a 50% lifetime discount!
Join over 2,000+ investors that have joined one of the leaders in cognitive healthcare.
This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. In addition, as described in the Offering Circular, the Company retains the right to continue the offering beyond the Termination Date, in its sole discretion.
05.17.23
Meet Dr. Andrew Hill, as featured on Joe Rogan’s show
Meet Dr. Andrew Hill. One of TruBrain’s Neuroscientists from UCLA, Dr. Hill has been a featured guest of Joe Rogan, Ben Greenfield, and Dr. Drew. Dr. Hill concentrated his studies on how attention operates in the brain, which helped in developing many of the personalized formulas that we offer. He played an integral role in the development and clinical research behind our best selling Drinks as well as our suite of other cognitive healthcare products. Dr. Hill received his PhD in Cognitive Neuroscience from UCLA and lectures at UCLA on the topic of healthy brain aging.
Learn more about the team disrupting an $11 Billion market
This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
05.15.23
Final Month to Invest!
This is the Final Month to invest in TruBrain! That means there are only 30 days left to get shares in the brand that is disrupting an $11 Billion market.
Don’t forget! TruBrain is profitable, with over $20 Million in sales, and has the backing of 4 Venture Capital Firms.
Invest now and get $325 worth of free product and up to a 50% lifetime discount!
Join over 2,000+ investors that have joined one of the leaders in cognitive healthcare.
This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. In addition, as described in the Offering Circular, the Company retains the right to continue the offering beyond the Termination Date, in its sole discretion.
05.09.23
TruBrain crosses $20M sold!
TruBrain increased profits by over 90% last year and has now crossed $20 Million in lifetime revenue. TruBrain continues to make strides as one of the leaders in the cognitive healthcare space. Join our investor community today!
Join over 2000+ investors that believe in TruBrain's growth
This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
05.04.23
TruBrain’s dedication for Mental Health Awareness Month
TruBrain is your digital clinic for cognitive health. Our PhD neuroscientists have designed all of our products to aid everything from customers’ memory & focus to anxiety & stress. Our new wearable devices are designed to help the 125M Americans that suffer with anxiety and help to calm their brain and find new ways to unlock their full cognitive potential.
See why TruBrain is one of the leaders in cognitive healthcare
This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
05.01.23
At-home Neurostimulation goes mainstream - NBC News
We are excited about the NBC News piece covering neurostimulation. The growing interest in cognitive enhancement suggests that people are becoming more aware of the potential of the human brain and acceptance for non-pharmaceutical solutions. As we continue to learn more about how the brain works and how we can improve its functioning, we can discover new ways to unlock our full cognitive potential. This could have far-reaching implications for everything from education and creativity to health and wellness.
Here is your opportunity to invest in this $11B market going mainstream
This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
Stack Owner's Bonus & Rewards!
Members get an extra 10% shares in addition to rewards below!
REWARDS
$473
StartEngine Owner’s Bonus
This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.
$473
Tier 1
Product Bundle (includes 1 Medium Capsules, 1 Extra Strength Capsules, and 1 TruBrain merchandise).
$1,450
Tier 2
Product Bundle (includes 1 Medium Capsules, 1 Extra Strength Capsules, 1 TruBrain merchandise, and 1 TruBrain wearable device).
$2,950
Tier 3
30% Lifetime discount on our products. + Product Bundle (includes 1 Medium Capsules, 1 Extra Strength Capsules, 1 TruBrain merchandise, and 1 TruBrain wearable device).
$4,950
Tier 4
40% Lifetime discount on our products.*, 5% Bonus Shares, Product Bundle (includes 1 Medium Capsules, 1 Extra Strength Capsules, 1 TruBrain merchandise, and 1 TruBrain wearable device).
$9,950
Tier 5
50% Lifetime discount on our products., 10% Bonus Shares, Product Bundle (includes 1 Medium Capsules, 1 Extra Strength Capsules, 1 TruBrain merchandise, and 1 TruBrain wearable device)., Beta test group.
$24,950
Tier 6
50% Lifetime discount on our products, 15% Bonus Shares, Product Bundle (includes 1 Medium Capsules, 1 Extra Strength Capsules, 1 TruBrain merchandise, and 1 TruBrain wearable device), Annual conference call with TruBrain’s CEO Meeting.
JOIN THE DISCUSSION
0/2500
PINNED BY STARTUP
TruBrain IR
a year ago
Hi All, we wanted to post a comment a top FAQ we are getting right now, so that it’s not hidden behind a reply
thread. Sorry there has been some trouble for investors locating shares.
Q: Where are my TruBrain Shares?
A: All shares now at startengine.com
TruBrain is pleased to announce the appointment of Start Engine as our official Transfer Agent to manage your shareholder account and provide you with the best services possible. Your shareholder records and investment information has automatically been transferred to Start Engine. All shares are now in one place.
Where can I see my shares?
Your shares in TruBrain will be managed by Start Engine. You will be able to access them via the Start Engine Investor Dashboard. If you do not have a Start Engine account set-up, you will be able to access your shares by emailing their Investor Relations team at contact@startengine.com, where they will be able to provide you with access to your records.
What is a Transfer Agent?
The transfer agent is a back office operational partner that exists to make for a smooth custodial process for investors. This will be your point of contact when you choose to login and view your shares or have any questions related to your managing your shares.
What does this mean for me?
This change strictly impacts where you will login to access your shares. You are still an owner in TruBrain. No matter what, every investor in this campaign and all of our past and future campaigns receives Shares, Perks, and a complete follow-through on our commitments in full.
I couldn’t find my shares. What was the problem?
We were in the process of adding EQ for transfer agent services because it seemed like a favorable deal for the Company at the time. However, we soon realized this was a mistake on our part. We are working now to correct this mistake and get all shares in one place (Start Engine).
Part 1 of 2...
0
0
Timothy huckaby
9 hours ago
What is your yoy growth and monthly avg growth? What are your margins net? How do you plan to increase margins further? Can you talk about your distribution plans and other potential products or areas of interest you might like or would be considering ..thinking of investing... What was your profit bet last 12 to 24 months last two years consecutive..thanks
0
0
Jayson Krisell
16 days ago
I received the email about the perks towards the end of April, filled out the form with shirt size and what I was interested in, etc. I still havent received any of the products. Just curious when it would be sent.
thank you
3
0
Andy Kocharian
40 INVESTMENTS
18 days ago
Where can I buy one.
1
0
Gregory Hoglund
2 months ago
When and where will persons buy the wearable anxiety tech?
1
0
Stephen Walsh
18 INVESTMENTS
2 months ago
I recently receive a partial perk for $1450 investment. I received a jar of extra trubrain 90 capsules and a T-shirt. I was wondering if I was going to receive the other perks and when?
1
0
Malvin Colon
7 INVESTMENTS
2 months ago
Hi-
I would like to make an investment, but i would like to know if I am investing in TRUE BRAIN or I'm I investing in TRIPLE PULSE INC.
Please let me know as I see TRUEBRAIN everywhere but TRIPLE PULSE WITHIN the terms of the contract...?? please let me know.
Thank You,
-Mal
1
0
Chris halling
3 months ago
Am I understanding correctly that if you select the $1,450 investment option the wearable device that will be included is the anxiety calming wearable discussed in the overview?
Does the wearable require any type of update for software or anything during the normal lifespan of the device?
Is there an age where this wearable is not suitable for people to wear? Kids, elderly, etc...? Has this device been studied on varying age groups without ill effects?
How has the company shielded itself from potential financial issues with banks like SVB or Signature bank having been taken over in receivership by the FDIC?
1
0
David J Peterson
2 INVESTMENTS
3 months ago
I invested in 2019 and am considering another investment. How does the TruBrain wearable tech differ from all the others on the market? Are there any studies that show this is any better than what's already out there? If not, will there be any? Proof that it works would go a long way into securing more investment dollars. Why should I invest more into TruBrain?
1
0
HOW INVESTING WORKS
Cancel anytime before 48 hours before a rolling close or the offering end date.
WHY STARTENGINE?
REWARDS
We want you to succeed and get the most out of your money by offering rewards and memberships!
SECURE
Your info is your info. We take pride in keeping it that way!
DIVERSE INVESTMENTS
Invest in over 200 start-ups and collectibles!
With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.
With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000, are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, he/she is limited to investing 10% of the greater of the two amounts.
At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.
Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.
StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market, or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.
For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.
For Regulation A+, StartEngine allows for a four-hour cancelation period. Once the four-hour window has passed, it is up to each company to set their own cancelation policy. You may find the company’s cancelation policy in the company’s offering circular.
Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.
Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to get sent back to the account associated with the investment.
Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.
PINNED BY STARTUP
TruBrain IR
a year ago
11
1